Torii Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was 円132,947 Mil.
During the past 12 months, Torii Pharmaceutical Co's average Total Assets Growth Rate was 11.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 16.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 8.70% per year.
During the past 10 years, the average Total Assets Growth Rate was 4.50% per year.
During the past 13 years, Torii Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 16.90%. The lowest was -16.40%. And the median was 4.95%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Torii Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Torii Pharmaceutical Co (TSE:4551) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Torii Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Torii Pharmaceutical Co Total Assets Related Terms
Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Torii Pharmaceutical Co (TSE:4551) Business Description
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4551 has been successfully added to your 